Healthcare utilisation in people living with HIV: the role of substance use, mood/anxiety disorders and unsustained viral suppression - a retrospective cohort study in British Columbia, Canada, 2001-2019

被引:0
作者
Shayegi-Nik, Sara [1 ]
Wang, Lu [2 ]
Magee, Carly [2 ]
Li, Jenny [2 ]
Budu, Michael [2 ]
Kooij, Katherine [2 ,3 ]
Honer, William G. [4 ]
Hogg, Robert S. [3 ,5 ]
Montaner, Julio S. G. [2 ,6 ]
Lima, Viviane D. [7 ]
机构
[1] Univ British Columbia, Expt Med, Vancouver Campus, Vancouver, BC, Canada
[2] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada
[3] Simon Fraser Univ, Burnaby, BC, Canada
[4] Univ British Columbia, Fac Med, Dept Psychiat, Vancouver, BC, Canada
[5] Fac Hlth Sci, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada
[6] Univ British Columbia, Fac Med, Vancouver, BC, Canada
[7] Univ British Columbia, Vancouver Campus, Vancouver, BC, Canada
来源
BMJ OPEN | 2025年 / 15卷 / 03期
基金
加拿大健康研究院;
关键词
HIV & AIDS; Health Services; Substance misuse; MENTAL HEALTH; Depression & mood disorders; 30-DAY HOSPITAL READMISSIONS; MENTAL-HEALTH; ANTIRETROVIRAL THERAPY; RESOURCE UTILIZATION; ALCOHOL-USE; PREVALENCE; OUTCOMES; RISK; INDIVIDUALS; COMORBIDITY;
D O I
10.1136/bmjopen-2024-088818
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective People living with HIV (PLWH) are disproportionately affected by substance use disorder (SUD) and mood/anxiety disorders, which are barriers to sustained viral suppression and can contribute to increased healthcare utilisations. This study examined the impact of SUD and mood/anxiety disorders on healthcare utilisation of PLWH with sustained and unsustained viral suppression. Design and participants This retrospective population-based cohort study used administrative data from 9757 antiretroviral-treated PLWH (83% men, median age 40 years). Eligible PLWH were >= 19 years of age, followed during 2001-2019, and achieved viral suppression at least once during follow-up. Setting This study was conducted in British Columbia, Canada. Measurements The exposure variable consisted of eight levels and included (1) sustained suppression, (2) SUD and mood/anxiety disorder diagnoses and the interaction between (1) and (2). Outcome variables included annual counts of primary care and specialist physician visits, laboratory visits, acute care hospitalisation, day surgery episodes and hospital length of stay (LOS). Statistical count models were used to determine the effect of exposure variables on each healthcare utilisation outcome while adjusting for socioeconomic confounders. Results In the presence of sustained suppression, having both disorders was significantly associated with over four times more acute-care hospitalisations (0.28 vs 0.05), three times longer LOS (9.1 vs 3.0 days) and almost double primary care physician (13.1 vs 6.9) and specialist (7.9 vs 4.0) visits. Overall, SUD alone was associated with increased use of all healthcare services (except day surgery). Regardless of disorder diagnoses, unsustained suppression was associated with higher healthcare utilisation (except day surgery). Conclusion In this study, SUD, mood/anxiety disorders and unsustained suppression, when combined, resulted in the highest healthcare utilisation among PLWH. The results suggest that providing comprehensive mental health and substance use services to PLWH and addressing barriers to sustained suppression could reduce the healthcare burden within this population.
引用
收藏
页数:12
相关论文
共 70 条
  • [1] Antoniou Tony, 2012, Open Med, V6, pe146
  • [2] A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization
    Azar, Marwan M.
    Springer, Sandra A.
    Meyer, Jaimie P.
    Altice, Frederick L.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2010, 112 (03) : 178 - 193
  • [3] British Columbia (BC) Ministry of Health, 2022, British Columbia Chronic Disease Registries (BCCDR) Case Definitions-Substance Use Disorder
  • [4] British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), 2019, Therapeutic guidelines antiretroviral (ARV) treatment of adult HIV infection
  • [5] British Columbia Chronic Disease Registries (BCCDR) Case Definitions, 2022, Mood and Anxiety Disorders
  • [6] British Columbia Ministry of Health, 2020, Medical Services Plan (MSP) Payment Information File. V2. Population Data BC. Data Extract
  • [7] British Columbia Ministry of Health, 2022, BC PharmaCare plans
  • [8] British Columbia Ministry of Health creator, 2021, Consolidation file (MSP Registration & Premium Billing)
  • [9] Canadas Source for HIV and hepatitis C information, 2018, Comparing substance use patterns among women in Canada
  • [10] Canadian Institute for Health Information, 2020, Discharge Abstract Database (Hospital Separations)